Can These 3 Pharma Companies Top Q2 Earnings Views?
Kate Stalter
In a research note published Friday, Bank of America analysts updated its expectationfs for pharmaceutical firms, including Amgen (NASDAQ: AMGN), AbbVie (NYSE: ABBV) and BioMarin (NASDAQ: BMRN) ahead of second-quarter earnings. The pharma industry is notoriously volatile, but Bank of America sees potential in several areas.
NYSE:ABBVNASDAQ:BMRNNASDAQ:AMGN